未登录

K

Kien Thiam Tan

chang gung memorial hospital

H指数:16

被引数:964

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Mutations in circulating tumor DNA detected in the postoperative period predict poor survival in patients with ovarian cancer

术后检测到的循环肿瘤DNA突变可预测卵巢癌患者的不良生存率

BIOMEDICAL JOURNAL

IF4.4

2023-10-016

OA

Plasma cell-free tumor DNA, PIK3CA and TP53 mutations predicted inferior endocrine-based treatment outcome in endocrine receptor-positive metastatic breast cancer

血浆无细胞肿瘤DNA，PIK3CA和TP53突变预测内分泌受体阳性转移性乳腺癌中基于内分泌的治疗结果较差

BREAST CANCER RESEARCH AND TREATMENT

IF3

2023-06-211

OAAI

Impaired Chromatin Remodeling Predicts Better Survival to Modified Gemcitabine and S-1 plus Nivolumab in Advanced Biliary Tract Cancer: A Phase II T1219 Study

CLINICAL CANCER RESEARCH

IF10.2

2022-07-189

OAAI

Comprehensive assessment of actionable genomic alterations in primary colorectal carcinoma using targeted next-generation sequencing

BRITISH JOURNAL OF CANCER

IF6.8

2022-07-1613

OA

The immune microenvironment features and response to immunotherapy in EBV-associated lymphoepithelioma-like cholangiocarcinoma

EBV相关淋巴上皮瘤样胆管癌的免疫微环境特征及对免疫治疗的反应

HEPATOLOGY INTERNATIONAL

IF6.1

2022-07-0314

PRE

Serial Tumor Molecular Profiling of Newly Diagnosed HER2-Negative Breast Cancers During Chemotherapy in Combination with Angiogenesis Inhibitors

TARGETED ONCOLOGY

IF4

2022-06-141

OAAI

Clinical impact of ESR1 mutation ctDNA on survival outcome is dependent on PI3KCA/TP53 ctDNA mutation status

CANCER RESEARCH

IF16.6

2022-02-150

PRE

Biological significance of MYC and CEBPD coamplification in urothelial carcinoma: Multilayered genomic, transcriptional and posttranscriptional positive feedback loops enhance oncogenic glycolysis

CLINICAL AND TRANSLATIONAL MEDICINE

IF6.8

2021-12-268

OAAI

Identification of actionable alterations in primary colorectal tumors using NGS-based comprehensive genomic profiling

ANNALS OF ONCOLOGY

IF65.4

2021-09-010

OAAI

Genetic alterations and their therapeutic implications in epithelial ovarian cancer

IF3.4

2021-05-0429

OAAI

Transient Response of Olaparib on Pulmonary Artery Sarcoma Harboring Multiple Homologous Recombinant Repair Gene Alterations

JOURNAL OF PERSONALIZED MEDICINE

IF3

2021-04-295

OAAI

Comprehensive genomic profiling reveals ubiquitousKRASmutations and frequentPIK3CAmutations in ovarian seromucinous borderline tumor

MODERN PATHOLOGY

IF5.5

2020-12-0113

OAAI

Genomic characterization reveals potential biomarkers in nasopharyngeal carcinoma patients with relapse

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

IF3.6

2020-11-066

PREAI

Genomic characterization reveals potential therapeutic targets in nasopharyngeal carcinoma with relapse

ANNALS OF ONCOLOGY

IF65.4

2020-09-010

OAAI

Panel-derived tumor mutational burden (TMB) is associated with the response to the immune checkpoint inhibitors (ICIs) in urothelial cancers

CANCER RESEARCH

IF16.6

2020-08-150

PREAI

Prognostic genomic alterations associated with recurrence after primary therapy for patients with luminal B breast cancer

CANCER RESEARCH

IF16.6

2020-08-150

PRE

A proteogenomic profile of early lung adenocarcinomas by protein co-expression network and genomic alteration analysis

SCIENTIFIC REPORTS

IF3.9

2020-08-124

OAAI

PIK3CA and ESR1 mutations detected in circulating tumor DNA (ctDNA) are predictive factors for late-line hormone-based therapies in ER+/HER2-metastatic breast cancer (MBC)

CANCER RESEARCH

IF16.6

2020-02-150

PRE

Maintenance of pegylated liposomal doxorubicin/carboplatin in patients with advanced ovarian cancer: randomized study of an Asian Gynecologic Oncology Group

晚期卵巢癌患者聚乙二醇化多柔比星/卡铂脂质体的维持: 亚洲妇科肿瘤学组的随机研究

JOURNAL OF GYNECOLOGIC ONCOLOGY

IF3.7

2020-01-015

OAAI

Genetic alterations in primary melanoma in Taiwan

BRITISH JOURNAL OF DERMATOLOGY

IF9.6

2019-10-1538

PREAI